Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
about
Novel Insights into the Roles of Rho Kinase in CancerImmune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious DiseasesROCK1 deficiency enhances protective effects of antioxidants against apoptosis and cell detachmentFasudil, a Clinically Used ROCK Inhibitor, Stabilizes Rod Photoreceptor Synapses after Retinal DetachmentFibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunctionROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell lineChronic treatment with Ang-(1-7) reverses abnormal reactivity in the corpus cavernosum and normalizes diabetes-induced changes in the protein levels of ACE, ACE2, ROCK1, ROCK2 and omega-hydroxylase in a rat model of type 1 diabetesThe effects of antenatal depression and antidepressant treatment on placental gene expression.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus.Development of second-generation small-molecule RhoA inhibitors with enhanced water solubility, tissue potency, and significant in vivo efficacy.Angiotensin II type I receptor blockade attenuates reflex cutaneous vasoconstriction in aged but not young skin.Stepwise high-throughput virtual screening of Rho kinase inhibitors from natural product library and potential therapeutics for pulmonary hypertension.Enhanced expression of ROCK in left atrial myocytes of mitral regurgitation: a potential mechanism of myolysis.The COP9 signalosome and vascular function: intriguing possibilities?Effect of fasudil on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition.Impacts of Rho kinase inhibitor Fasudil on Rho/ROCK signaling pathway in rabbits with optic nerve injury.RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell borderG-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.Copper as a key regulator of cell signalling pathways.Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.Novel investigational therapies for treating pulmonary arterial hypertension.Nonbiological pharmacotherapies for the treatment of diabetic macular edema.Stiff Substrates Increase Inflammation-Induced Endothelial Monolayer Tension and Permeability.Berberine and Its Role in Chronic Disease.ROK and Arteriolar Myogenic Tone Generation: Molecular Evidence in Health and Disease.Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.Diuretics prevent Rho-kinase activation and expression of profibrotic/oxidative genes in the hypertensive aortic wall.Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.Effects of CC-chemokine receptor 5 on ROCK2 and P-MLC2 expression after focal cerebral ischaemia-reperfusion injury in rats.Rho kinase inhibitors: potentially versatile therapy for the treatment of cardiovascular diseases and more.Inhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysmsBasal and Activated Calcium Sensitization Mediated by RhoA/Rho Kinase Pathway in Rats with Genetic and Salt Hypertension.Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury.Indoxyl sulfate potentiates endothelial dysfunction via reciprocal role for reactive oxygen species and RhoA/ROCK signaling in 5/6 nephrectomized rats.Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway.The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia.
P2860
Q26771368-18B9D625-C237-4907-AA49-F7B010F69241Q28081001-C90B7BC9-E5F4-4DB7-AA8B-63B910E2B813Q28540406-E2876561-96F9-4705-B96D-FAFE1B799D5CQ33828265-3D88B92B-A3F7-4D2B-8B9F-7E82E6D8102AQ33877795-79407D00-45E1-48D4-B39A-B7F01B5B1B25Q34215809-2484F49E-D6B0-4D97-A630-84643B15F3E8Q34275725-4C7A69BF-BFAD-49ED-9660-BA1CF77CB80DQ34936521-E1C2354E-B71E-4234-B026-CC5CCCB72B41Q35145862-A333B5E5-84F1-40AF-B8BE-B38E14E0A00BQ35401180-CAFC5B8B-2E08-4A2F-A3CF-0FAE42DB1125Q35577220-61048C71-DDA7-48A5-9E59-B2B20FC4BEADQ35597657-4CB7C006-8AA6-48D1-9188-9EE8ADD31882Q35599280-A8CB4373-CFCB-4A87-B704-6320EB43D3BEQ35700589-1454C7AE-72B5-4D0A-AF2B-1534C33F8EBEQ35805778-A3545673-EC24-42A0-AECB-92AE3C25D57AQ35824952-ACDFA014-BDCA-4A4F-B4E5-BAAEB7DAC62EQ36464589-588FCE66-3EDE-4DC0-8ED5-936FD4FF3530Q36887349-5826BF20-43FE-4CBB-991F-416561991D4AQ37122933-1275F9BE-48A0-478F-AA6B-72922B1EB506Q38213536-DB3CC3A0-32D5-496C-83D5-FCF8CE1828DBQ38367694-4E85C964-515E-4461-8893-1DDAD06B1266Q38612061-874F143D-AA5E-4E97-B805-0400D41CBF15Q38622256-44F1CB67-614B-4E61-905C-9A242D26CC91Q38632110-35B5CD6D-C2A3-4274-9F92-4BC828EA2A9FQ38965186-C4AB6921-8CE8-4618-96FC-D7D35A94DFEBQ39172063-79577E2B-EFA3-427B-BC68-5F51F49AF3DAQ39176512-76634FC1-AB9A-49F4-B827-DAD4051710F9Q39250080-FFF0A691-8B72-41FA-86BC-ADD29B12658FQ39429512-9524A141-43C5-40B0-9370-59218B6C840CQ39444002-7C0FF824-FE79-4496-AE38-F5195B6BE8ABQ39915027-27BFBC57-236B-40C6-B34D-45D9C5A2F1DFQ40151193-7459A462-839C-4769-8FDA-E38B236EB0B4Q41994097-15606393-C872-40F2-99C8-636BE176031DQ42009623-6C09FEA5-068E-4CC3-B331-17B114C73AC9Q42149118-0A40B2B5-A46B-4B89-B946-C804071479E5Q42490751-E55510BA-4BD8-42AB-9FF7-5079FA4F0A2AQ42703908-BC75038C-AB06-429D-8E48-097D7ED2D5F9Q46406577-D9E6FE62-1915-4C33-AB03-986382045814Q47270104-456F7FD5-99A7-4DB0-AF12-1BE9B88C46B5Q47775594-3CDFB371-08A5-4710-A479-31EA4F755DC7
P2860
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@en
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@nl
type
label
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@en
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@nl
prefLabel
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@en
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@nl
P2860
P1476
Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
@en
P2093
P2860
P304
P356
10.1097/FJC.0B013E3182A3718F
P407
P577
2013-10-01T00:00:00Z